SCHEMBL4197992

SCHEMBL4197992

C[C@@H](CC1CCCCC1)NCc1ccccc1NS(=O)(=O)c1cccc(NS(=O)(=O)c2cccs2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 3/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 4/20 0.40
ADRB2 P07550 2/20 0.40
ADRB1 P08588 2/20 0.40
ADRB3 P13945 2/20 0.40
BCHE P06276 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.39
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
CCR2 P41597 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202523 0.91 PKM (0.51) MEN1KMT2AHPGDNPC1PKM
SCHEMBL4198105 0.90 NPC1 (0.49) MEN1KMT2AHPGDNPC1PKM
SCHEMBL4194027 0.90 PKM (0.52) MEN1KMT2AHPGDNPC1PKM
SCHEMBL4199654 0.89 NPC1 (0.50) MEN1KMT2AHPGDNPC1PKM
SCHEMBL4189973 0.88 PKM (0.42) MEN1KMT2ANPC1PKMKDM4E
SCHEMBL4194882 0.87 KDM4E (0.41) MEN1KMT2APKMKDM4EALDH1A1
SCHEMBL4189913 0.87 KDM4E (0.45) MEN1KMT2APKMKDM4EALDH1A1
SCHEMBL4195557 0.86 NPC1 (0.39) MEN1KMT2AHPGDNPC1PKM
SCHEMBL4195424 0.86 PKM (0.53) MEN1KMT2ANPC1PKMKDM4E
SCHEMBL4189902 0.86 NPC1 (0.45) HPGDNPC1PKMKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 MEN1 3776/4885KMT2A 2047/4885HPGD 2593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.